Department of Surgery, Hôpital du Chablais, 1860, Aigle-Monthey, Switzerland.
Obes Surg. 2014 Jan;24(1):114-22. doi: 10.1007/s11695-013-1074-0.
Gastric banding still represents one of the most widely used bariatric procedures. It provides acceptable weight loss in many patients, but has frequent long-term complications. Because different types of bands may lead to different results, we designed a randomized study to compare the Lapband® with the SAGB®. We hereby report on the long-term results.
Between December 1998 and June 2002, 180 morbidly obese patients were randomized between Lapband® or SAGB®. Weight loss, long-term morbidity, and need for reoperation were evaluated.
Long-term weight loss did not differ between the two bands. Patients who maintained their band had an acceptable long-term weight loss of between 50 and 60 % EBMIL. In both groups, about half the patients developed long-term complications, with about 50 % requiring major redo surgery. There was no difference in the overall rates of long-term complications or failures between the two groups, but patients who had a Lapband® were significantly more prone to develop band slippage/pouch dilatation (13.3 versus 0 %, p < 0,001).
Although in the absence of complication, gastric banding leads to acceptable weight loss; the long-term complication and major reoperation rates are very high independently from the type of band used or on the operative technique. Gastric banding leads to relatively poor overall long-term results and therefore should not be considered the procedure of choice for the treatment of morbid obesity. Patients should be informed of the limited overall weight loss and the very high complication rates.
胃带仍然是最广泛使用的减肥手术之一。它可以为许多患者提供可接受的体重减轻,但存在频繁的长期并发症。由于不同类型的带可能会导致不同的结果,我们设计了一项随机研究来比较 Lapband®和 SAGB®。我们在此报告长期结果。
1998 年 12 月至 2002 年 6 月期间,180 名病态肥胖患者被随机分为 Lapband®或 SAGB®组。评估体重减轻、长期发病率和再次手术的需要。
两种带之间的长期减重效果没有差异。保持带的患者长期体重减轻可接受,介于 50%至 60% EBMIL 之间。在两组中,约一半的患者出现长期并发症,约 50%需要进行重大再手术。两组之间长期并发症或失败的总体发生率没有差异,但 Lapband®组发生带滑脱/囊扩张的风险明显更高(13.3%对 0%,p<0.001)。
尽管在没有并发症的情况下,胃带可以导致可接受的体重减轻;但长期并发症和重大再手术的发生率非常高,与使用的带类型或手术技术无关。胃带导致相对较差的整体长期结果,因此不应被视为治疗病态肥胖的首选方法。应告知患者整体体重减轻有限和高并发症发生率的情况。